BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 398976)

  • 21. [Clinical evaluation of a new oral cephem, cefprozil in children].
    Meguro H; Tajima T; Shiraishi H; Abe T
    Jpn J Antibiot; 1992 Nov; 45(11):1505-13. PubMed ID: 1494233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative studies of the antibacterial effect of so-called basic cephalosporins].
    Ruckdeschel G
    Med Klin (Munich); 1988 Dec; 83(24):825-31. PubMed ID: 3062348
    [No Abstract]   [Full Text] [Related]  

  • 23. [In vitro action and therapeutic evaluation of cefuroxime in acute bacterial infections in pediatrics].
    Russ C; Sarachian B; Corthey C; Stamboulian D
    Medicina (B Aires); 1983; 43(3):354-5. PubMed ID: 6672520
    [No Abstract]   [Full Text] [Related]  

  • 24. Consensus report: antimicrobial therapy for bacterial meningitis in infants and children.
    McCracken GH; Nelson JD; Kaplan SL; Overturf GD; Rodriguez WJ; Steele RW
    Pediatr Infect Dis J; 1987 Jun; 6(6):501-5. PubMed ID: 3615064
    [No Abstract]   [Full Text] [Related]  

  • 25. [Ampicillin and combination penicillins in clinical medicine (antibacterial effects)].
    Metz H
    Munch Med Wochenschr; 1972 Sep; 114(35):1515-9. PubMed ID: 4628080
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cephazolin: bacteriological study and clinical results].
    Bertrand A; Janbon F; Despaux E; Jourdan J
    Nouv Presse Med; 1974 Apr; 3(0):28-32. PubMed ID: 4599827
    [No Abstract]   [Full Text] [Related]  

  • 27. Antibiotic therapy for severe infections in infants and children.
    Rhodes KH; Johnson CM
    Mayo Clin Proc; 1983 Mar; 58(3):158-64. PubMed ID: 6827859
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro and in vivo microbiological evaluations of cefoperazone.
    Renzini G; Ravagnan G; Piccolomini R; Dainelli B; Comanducci A
    Clin Ther; 1980; 3(Spec Issue):139-44. PubMed ID: 6446388
    [No Abstract]   [Full Text] [Related]  

  • 29. [Profile of antimicrobial resistance of agents causing urinary tract infections in children].
    Ghedira Besbes L; Messaoudi A; Ben Meriem C; Guediche MN
    Tunis Med; 2004 Mar; 82(3):299-305. PubMed ID: 15382465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antibiotic therapy: use and clinical evaluation of a new antibacterial drug, ceftazidime (RG 159) administered parenterally in children].
    Pavesio D; Mora P; Oggero R; Ricca V
    Minerva Pediatr; 1984 May; 36(9):481-92. PubMed ID: 6381981
    [No Abstract]   [Full Text] [Related]  

  • 31. Microbiology of oral cephalosporins.
    Cullmann W
    Antibiot Chemother (1971); 1995; 47():72-109. PubMed ID: 8554308
    [No Abstract]   [Full Text] [Related]  

  • 32. [Bacteriological, pharmacological and clinical study of cephazolin].
    Tancrède C; Betourné C
    Nouv Presse Med; 1974 Apr; 3(0):34-7. PubMed ID: 4600178
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical significance of Cephalosporins in childhood].
    Weippl G
    Wien Med Wochenschr Suppl; 1975; 27():23-6. PubMed ID: 1064251
    [No Abstract]   [Full Text] [Related]  

  • 34. Choice of cephalosporins.
    Med Lett Drugs Ther; 1990 Nov; 32(832):107-10. PubMed ID: 2243553
    [No Abstract]   [Full Text] [Related]  

  • 35. [The current importance of semisynthetic cephalosporins in the antibiotic therapy of bacterial infections (informational data)].
    Treskina OS; Navashin SM
    Antibiot Khimioter; 1988 Nov; 33(11):850-5. PubMed ID: 3228329
    [No Abstract]   [Full Text] [Related]  

  • 36. An epidemiological study of three cephalosporins: cefotetan, cefixime and cefpirome.
    Fabius GT; Niël-Weise B; Jeronimus A
    J Chemother; 1989 Jul; 1(4 Suppl):113-6. PubMed ID: 16312330
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of neonatal infections: the place of cephalosporins].
    Aujard Y
    Presse Med; 1987 Dec; 16(43):2176-9. PubMed ID: 2963307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Oral cephalosporins in the treatment of suppurative-inflammatory diseases].
    Sidorenko SV
    Antibiot Khimioter; 1996; 41(11):33-42. PubMed ID: 9214285
    [No Abstract]   [Full Text] [Related]  

  • 39. A strategy for evaluating which of the new cephalosporins to use.
    Yogev R
    Pediatr Ann; 1986 Jun; 15(6):470-1, 474-7. PubMed ID: 3725440
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical and laboratory studies of a new cephalosporin derivative--cefathiamidine.
    Tze-ying T; Fu W; Chih-lin C; Mei-fang C; Ching-teh C; Ying-yuan C; Yu-kun L
    Chin Med J (Engl); 1979 Jan; 92(1):26-36. PubMed ID: 105842
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.